18 Dec 2017
Mereo Plans to Conduct Registered Initial Public Offering in the U.S.
View Press Release
13 Dec 2017
Business update
View press release
11 Dec 2017
Mereo announces positive top-line results from Phase 2 trial with BCT-197 (acumapimod)
View Press Release
13 Nov 2017
Mereo receives EMA PRIME designation for BPS-804 to treat osteogenesis imperfecta
View press release
30 Oct 2017
Mereo BioPharma announces agreement with AstraZeneca AB for an exclusive license and option to acquire AZD9668
View press release

Regulatory News

Keep up to date with our financial regulatory news and developments.

View our regulatory news

Corporate Presentation

View our latest Corporate Presentation

View Presentation